CEL-SCI Announces Change To The Date Of Its Annual Meeting Post author:Sam Post published:May 11, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Biocon's Biosimilar Arm May Raise $500M to Fund Clinical Development December 21, 2017 Alimera Sciences Reports Record Fourth Quarter And Full Year 2016 Financial Results March 1, 2017 Ipsen Announces FDA Approval Of Dysport (Abobotulinumtoxina) For The Treatment Of Lower Limb Spasticity In Adults June 15, 2017
Ipsen Announces FDA Approval Of Dysport (Abobotulinumtoxina) For The Treatment Of Lower Limb Spasticity In Adults June 15, 2017